ADAP

Adaptimmune Therapeutics

82 hedge funds and large institutions have $476M invested in Adaptimmune Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 12 closing their positions.

Holders
82
Holders Change
-2
Holders Change %
-2.38%
% of All Funds
1.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
27
Reduced
22
Closed
12
Calls
$692K
Puts
$691K
Net Calls
+$1K
Net Calls Change
+$127K
Name Market Value Shares Shares
Change
Shares
Change %
S
76
SignatureFD
Georgia
$1K 224 -720 -76%
Daiwa Securities Group
77
Daiwa Securities Group
Japan
$1K 256
CHA
78
Carmichael Hill & Associates
Maryland
$1K 210 +90 +75%
HI
79
Harbour Investments
Wisconsin
$1K 225 +200 +800%
ED
80
Exane Derivatives
France
$468 121
OAMG
81
Odey Asset Management Group
United Kingdom
-550,867 Closed
GAMA
82
Graticule Asia Macro Advisors
New York
-346,500 Closed
California Public Employees Retirement System
83
California Public Employees Retirement System
California
-250,800 Closed
QI
84
QS Investors
New York
-138,000 Closed
TI
85
Trexquant Investment
Connecticut
-46,742 Closed
EGM
86
Engineers Gate Manager
New York
-39,100 Closed
HAIM
87
Hunter Associates Investment Management
Pennsylvania
-15,825 Closed
Barclays
88
Barclays
United Kingdom
$0 49 -8,140 -99%
PAM
89
Panagora Asset Management
Massachusetts
-5,975 Closed
GWM
90
Geneos Wealth Management
Colorado
-3,260 Closed
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
-3,000 Closed
TCWM
92
Total Clarity Wealth Management
Illinois
-1,200 Closed
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
-660 Closed
CFGS
94
Concourse Financial Group Securities
Alabama
HT
95
HAP Trading
New York
Osaic Holdings
96
Osaic Holdings
Arizona
$0 50 +50 New